It's Not Just About Getting High - Seven Marijuana Stocks

"On Thursday, January 22, CNBC will be presenting a program called Marijuana Inc., which goes into depth about the big business of marijuana. But besides the illegal uses of marijuana, there are many medical uses....

Emerging Clinical Applications For Cannabis & Cannabinoids

"Emerging Clinical Applications For Cannabis & CannabinoidsA Review of the Recent Scientific Literature, 2000 — 2008 Despite continued political debates regarding the legality of medicinal marijuana, clinical investigations of the therapeutic use of cannabinoids are...

Treatment of Tourette’s syndrome with delta-9-tetrahydrocannabinol.

"Tourette’s Syndrome Tourette’s syndrome (TS) is a complex neuropsychiatric disorder of unknown etiology that is characterized by involuntary vocal tics. Severity of this condition varies widely among patients. Though there is no cure for...

Would you believe....Cannabis for WEIGHT LOSS ?

"The Endocannabinoid SystemCannabis preparations have been used medically for thousands of years for illnesses such as epilepsy, migraine headaches, childbirth, and menstrual symptoms. However, it is only relatively recently that the active components have been identified and...

Big Pharma pushes for patents of pot-based pills

I found this statistic surprising: in 1994 there were only two pot-based pharmaceutical drugs in development in the US, while in 2004 there were 27. That's a big leap, one that could potentially hold some clout in...

First Results of Merck’s Taranabant Promising for Weight Loss

A new study suggests that the experimental drug taranabant causes people to both consume fewer calories and burn more.

Cannabinoid Agonist Significantly Increases ALS Life Span, Study Says

"Little Rock, AR: Administration of the selective cannabinoid agonist AM-1241 significantly increases the survival of mice with amyotrophic lateral sclerosis (ALS) and may ultimately lead to the development of new cannabis-based medications to treat the disease in humans,...

closeSign in to NowPublic

is reporting from